IFRX

#3739
InflaRx N.V. - Common Stock
2.1 4 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.13
2.15
Intervallo Annuale
0.80
2.94
Variazione giornaliera
-4.04%
Variazione Mensile
+27.38%
Variazione di 6 mesi
+140.45%
Variazione Annuale
+27.38%
Chiusura Precedente
2.2 3
Open
2.1 4
Minimo
2.1 3
Massimo
2.1 5
Volume
56
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Inflarx N.V. current report, Q3 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
Inflarx N.V. current report, Q2 FY2026
6-K
Current report, Q1 FY2026
Inflarx N.V. current report, Q1 FY2026
6-K

Inflarx N.V. current report, Q3 FY2025

Full document

Business Context and Reporting Period

This Form 6-K filing by InflaRx N.V. covers the month of July 2025, with the report dated July 14, 2025. The filing primarily addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the Company's compliance with listing standards.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a listing status issue rather than a financial results announcement.

Material Changes

The material change reported is the receipt of a written notice from Nasdaq on July 11, 2025. The notice indicates that for the last 30 consecutive business days, the bid price for InflaRx N.V.'s ordinary shares closed below the minimum $1.00 per share requirement under Nasdaq Listing Rule 5450(a)(1).

Outlook, Risks, and Management Commentary

  • Compliance Timeline: The Company has an initial period of 180 calendar days, until January 7, 2026, to regain compliance with the Minimum Bid Price Rule.
  • Contingency Plan: If compliance is not achieved by the initial deadline, the Company may consider transferring its securities from The Nasdaq Global Select Market to The Nasdaq Capital Market. This transfer, if approved, would provide an additional 180 calendar days (until July 6, 2026) to regain compliance.
  • Uncertainties: There is no assurance that the Company will be eligible for the additional compliance period or that Nasdaq staff will grant the request for continued listing.
  • Immediate Impact: The notice has no immediate effect on the listing or trading of the Company's ordinary shares.
  • Management Action: Management intends to monitor the bid price and consider available options to regain compliance.

Investor Verification Checklist

  • Verify the current bid price of InflaRx N.V. shares to assess the severity of the delisting risk.
  • Monitor the Company's progress toward regaining compliance before the January 7, 2026 deadline.
  • Review future filings for any announcement regarding a potential transfer to The Nasdaq Capital Market.
  • Check for any subsequent press releases detailing specific strategies (e.g., reverse stock splits) to address the low share price.

Notizie